GlassScriptPhysician profile
Lunan Ji
NPI 1851719629
$7,165.30
in general payments reported to CMS, 2019-2025
26 companies · $1,774 in 2025
The $1,774 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $539 · 2021: $298 · 2022: $715 · 2023: $1,353 · 2024: $1,851 · 2025: $1,774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,856 · Travel and Lodging: $2,086 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,856.02 |
| Travel and Lodging | $2,086.41 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,515.79 | 2020-2025 | Aquabeam System |
| Medtronic, INC. | $1,156.04 | 2022-2025 | Altaviva |
| Boston Scientific Corporation | $969.40 | 2019-2025 | Ams 700, Axonics |
| Axonics, INC. | $668.74 | 2021-2024 | Axonics |
| Coloplast Corp | $643.62 | 2019-2025 | Speedicath |
| Sumitomo Pharma America, INC. | $440.02 | 2023-2025 | Gemtesa |
| Olympus America INC. | $334.00 | 2022-2023 | Soltive, Olympus, Itind System |
| Astellas Pharma US INC | $237.38 | 2021-2024 | Myrbetriq |
| 180 Medical, INC. | $165.20 | 2022-2024 | Gentlecath, Cure Catheter |
| Urovant Sciences INC | $159.78 | 2022 | |
| Caldera Medical, INC | $132.70 | 2022-2023 | Desara |
| Endo Pharmaceuticals INC. | $105.76 | 2021-2024 | Xiaflex |
| Endo USA, INC. | $85.77 | 2025 | Xiaflex |
| Integra Lifesciences Corporation | $81.71 | 2019 | |
| Cook Medical LLC | $75.00 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $73.67 | 2023-2025 | |
| Allergan, INC. | $51.63 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $50.81 | 2023 | |
| Teleflex LLC | $41.84 | 2024 | Urolift |
| C. R. Bard, INC. & Subsidiaries | $40.08 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Urogen Pharma, INC. | $29.04 | 2024 | |
| Becton, Dickinson and Company | $20.35 | 2025 | Bard Urinary Drainage Bag |
| Valencia Technologies Corporation | $17.83 | 2025 | Ecoin Device Kit |
| Kowa Pharmaceuticals America, INC. | $17.42 | 2022 | |
| Laborie Medical Technologies Corp. | $16.66 | 2024 | Urgent PC Neuromodulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lunan Ji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.